319 related articles for article (PubMed ID: 20551454)
1. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study.
Dent J; Vakil N; Jones R; Bytzer P; Schöning U; Halling K; Junghard O; Lind T
Gut; 2010 Jun; 59(6):714-21. PubMed ID: 20551454
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
[TBL] [Abstract][Full Text] [Related]
3. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease.
Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J
Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439
[TBL] [Abstract][Full Text] [Related]
4. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association.
Aanen MC; Weusten BL; Numans ME; de Wit NJ; Samsom M; Smout AJ
J Clin Gastroenterol; 2008; 42(5):441-7. PubMed ID: 18344896
[TBL] [Abstract][Full Text] [Related]
5. A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial.
Boeckxstaens GE; Beaumont H; Hatlebakk JG; Silberg DG; Björck K; Karlsson M; Denison H
Gut; 2011 Sep; 60(9):1182-8. PubMed ID: 21402616
[TBL] [Abstract][Full Text] [Related]
6. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease.
Johnsson F; Hatlebakk JG; Klintenberg AC; Román J; Toth E; Stubberöd A; Falk A; Edin R
Scand J Gastroenterol; 2003 Apr; 38(4):354-9. PubMed ID: 12739706
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of the Reflux Disease Questionnaire in general practice.
Aanen MC; Numans ME; Weusten BL; Smout AJ
Digestion; 2006; 74(3-4):162-8. PubMed ID: 17351321
[TBL] [Abstract][Full Text] [Related]
8. Symptom overlap in patients with upper gastrointestinal complaints in the Canadian confirmatory acid suppression test (CAST) study: further psychometric validation of the reflux disease questionnaire.
van Zanten SV; Armstrong D; Barkun A; Junghard O; White RJ; Wiklund IK
Aliment Pharmacol Ther; 2007 May; 25(9):1087-97. PubMed ID: 17439510
[TBL] [Abstract][Full Text] [Related]
9. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.
Zerbib F; Belhocine K; Simon M; Capdepont M; Mion F; Bruley des Varannes S; Galmiche JP
Gut; 2012 Apr; 61(4):501-6. PubMed ID: 21997546
[TBL] [Abstract][Full Text] [Related]
10. Atypical symptoms of GORD in Belgium: epidemiological features, current management and open label treatment with 40 mg esomeprazole for one month.
Louis E; Jorissen P; Bastens B; D'Haens G; Schoofs N; Burette A; Christiaens P; Tack J;
Acta Gastroenterol Belg; 2006; 69(2):203-8. PubMed ID: 16929616
[TBL] [Abstract][Full Text] [Related]
11. Relationship between symptom response and esophageal pH level on standard dose of esomeprazole treatment for gastroesophageal reflux disease.
Peng S; Xiong LS; Xiao YL; Wang AJ; Lin JK; Hu PJ; Chen MH
Chin Med J (Engl); 2010 Aug; 123(15):2012-7. PubMed ID: 20819534
[TBL] [Abstract][Full Text] [Related]
12. Reflux episodes detected by impedance in patients on and off esomeprazole: a randomised double-blinded placebo-controlled crossover study.
Moawad FJ; Betteridge JD; Boger JA; Cheng FK; Belle LS; Chen YJ; Maydonovitch CL; Wong RK
Aliment Pharmacol Ther; 2013 May; 37(10):1011-8. PubMed ID: 23560727
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of esomeprazole 40 mg in patients with persistent symptoms of gastro-oesophageal reflux disease following treatment with a full dose proton pump inhibitor.
Jones R; Patrikios T
Int J Clin Pract; 2008 Dec; 62(12):1844-50. PubMed ID: 19166433
[TBL] [Abstract][Full Text] [Related]
14. Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.
Johnson D; Crawley JA; Hwang C; Brown K
Aliment Pharmacol Ther; 2010 Jul; 32(2):182-90. PubMed ID: 20456306
[TBL] [Abstract][Full Text] [Related]
15. Concomitant symptoms itemized in the Reflux Disease Questionnaire are associated with attenuated heartburn response to acid suppression.
Kahrilas PJ; Jonsson A; Denison H; Wernersson B; Hughes N; Howden CW
Am J Gastroenterol; 2012 Sep; 107(9):1354-60. PubMed ID: 22777339
[TBL] [Abstract][Full Text] [Related]
16. Correlation between oesophageal acid exposure and dyspeptic symptoms in patients with nonerosive reflux disease.
Sarnelli G; De Giorgi F; Efficie E; Aprea G; Masone S; Savarese MF; Esposito I; Russo L; Cuomo R
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):264-8. PubMed ID: 18334868
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of esomeprazole and fundoplication on airway responsiveness in patients with gastro-oesophageal reflux disease.
Kiljander T; Rantanen T; Kellokumpu I; Kööbi T; Lammi L; Nieminen M; Poussa T; Ranta A; Saarelainen S; Salminen P
Clin Respir J; 2013 Jul; 7(3):281-7. PubMed ID: 23006321
[TBL] [Abstract][Full Text] [Related]
18. Chronic cough and esomeprazole: a double-blind placebo-controlled parallel study.
Faruqi S; Molyneux ID; Fathi H; Wright C; Thompson R; Morice AH
Respirology; 2011 Oct; 16(7):1150-6. PubMed ID: 21707852
[TBL] [Abstract][Full Text] [Related]
19. Esomeprazole reduces gastroesophageal reflux after beer consumption in healthy volunteers.
Franke A; Hepp C; Harder H; Beglinger C; Singer MV
Scand J Gastroenterol; 2008; 43(12):1425-31. PubMed ID: 18924018
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of gastro-oesophageal reflux disease with upper gastrointestinal symptoms without heartburn and regurgitation.
Vakil N; Wernersson B; Ohlsson L; Dent J
United European Gastroenterol J; 2014 Jun; 2(3):173-8. PubMed ID: 25360300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
